A recent study indicates that patients who discontinue new weight-loss injections like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who halt conventional lifestyle regimens.
Findings released in a major medical journal shows that while obese people often shed substantial amounts of their total mass while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals using these treatments need to be cognizant of the risk of fast rebound weight gain when the therapy is stopped," stated expert Dr. Susan Jebb.
This pace of recovery implies a return to original mass within about a year and a half.
Weighing Approaches
The research, which examined 37 of studies involving thousands of participants, contrasted the results of GLP-1 agonists with older methods.
Researchers emphasize that individuals who lose weight through lifestyle changes alone generally see a less rapid weight regain—approximately 100 grams monthly—once they finish.
Explaining the Rapid Regain
Nutrition scientists believe the mechanism of the drugs accounts for the amplified rebound.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing GLP-1 concentrations several times higher than normal may cause the system to generate a reduced amount of its endogenous hormone, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this hormone supplement leads to hunger is no longer kept in check, making overeating a significant risk."
A Lifelong Condition?
Health authorities recommend the injections for people with obesity-related health risks, alongside prescribed diet and exercise modifications.
A number of clinicians say that, given the high risk of weight regain, the treatment should be considered ongoing.
This opinion is echoed by drug manufacturers, who note that the findings "underscore the long-term character of excess weight," comparing it to managing conditions like hypertension.
User Testimonies
People who have stopped the medication explain a intense resurgence of hunger.
"I experienced a trigger that goes on and you become ravenous," said one woman.
The struggle is compounded if patients have not established permanent lifestyle or habit modifications during treatment.
Significant Use
Recent estimates suggest that a significant number of people in the UK have used these injections in the last 12 months, with interest continuing to grow.
- Use is more common among females than men.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than public health services.
Ultimately, experts stress that while these medications are powerful agents for weight loss, they are not a standalone cure and lasting health benefits likely depends on combined lifestyle support.
